Assessment of anti-factor Xa activity of enoxaparin for venous thromboembolism prophylaxis in morbidly obese surgical patients

Assessment of anti-factor Xa activity of enoxaparin for venous thromboembolism prophylaxis in morbidly obese surgical patients

Background: Venous thromboembolism (VTE) can be encountered by 60% of hospitalized patients. Anticoagulants have been recommended to reduce the risk of VTE in patients with risk factors. However, no specific dosing recommendations for obese patients are provided in the current practice guidelines. T...

Full description

Bibliographic Details
Main Authors: Nouf Al Otaib, Zohour Bootah, Maha A Al Ammari, Tariq M Aldebasi, Abdulmalik M Alkatheri, Shmeylan A Al Harbi, Salah M AbuRuz, Abdulkareem M AlBekairy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Annals of Thoracic Medicine
Subjects:
Low molecular weight heparin
obese
surgery
venous thromboembolism
weight-based dose
Online Access:http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2017;volume=12;issue=3;spage=199;epage=203;aulast=Al

Internet

http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2017;volume=12;issue=3;spage=199;epage=203;aulast=Al

Similar Items